NCT00203034View on ClinicalTrials.gov

Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

PHASE3CompletedINTERVENTIONAL
Enrollment

472

Participants

Timeline

Start Date

May 31, 2000

Primary Completion Date

January 31, 2003

Study Completion Date

January 31, 2003

Conditions
Parkinson's Disease
Interventions
DRUG

rasagiline mesylate

0.5 mg rasagiline mesylate oral once daily

DRUG

1.0 mg rasagiline mesylate

1.0 mg rasagiline mesylate oral once daily

OTHER

Placebo

oral placebo once daily

Trial Locations (4)

10032

Columbia - Presbyterian Medical Center, New York

14642

University of Rochester, Rochester

60612

Rush - Presbyterian St. Luke's Medical Center, Chicago

77030

Baylor College of Medicine, Houston

All Listed Sponsors
lead

Teva Branded Pharmaceutical Products R&D, Inc.

INDUSTRY

NCT00203034 - Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations | Biotech Hunter | Biotech Hunter